Back to search

Article

5β-Dihydrotestosterone reveals a mutant androgen receptor vulnerability in prostate cancer

2026-07-15

Abstract excerpt

Bipolar androgen therapy (BAT) exploits the paradoxical vulnerability of castration-resistant prostate cancer (CRPC) cells to rapid cycling between castrate and supraphysiologic androgen concentrations, but clinical BAT uses testosterone, which can also activate wild-type androgen receptor (AR) in androgen-responsive tissues, causing systemic side effects. 5β-dihydrotestosterone (5β-DHT) is a naturally occurring t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f16d5ecf-882c-5dd4-ac37-ebc7d5a43b99
DOI
10.64898/2026.07.14.738538
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
5β-Dihydrotestosterone reveals a mutant androgen receptor vulnerability in prostate cancerDOI 10.64898/2026.07.14.738538
Select a neighboring publication to make it the new centre.